Aberrant Bone Regulation in Albright Hereditary Osteodystrophy dueto Gnas Inactivation: Mechanisms and Translational Implications

被引:5
|
作者
McMullan, Patrick [1 ,2 ]
Germain-Lee, Emily L. [1 ,2 ,3 ]
机构
[1] Univ Connecticut, Dept Pediat, Div Pediat Endocrinol & Diabet, Sch Med, 505 Farmington Ave,2nd Floor, Farmington, CT 06032 USA
[2] Univ Connecticut, Sch Dent Med, Dept Reconstruct Sci, Ctr Regenerat Med & Skeletal Dev, Farmington, CT 06032 USA
[3] Connecticut Childrens, Albright Ctr, Farmington, CT 06032 USA
基金
美国国家卫生研究院;
关键词
Gnas; Bone remodeling; Heterotopic ossification; Osteoclast; Osteocyte; Osteoblast; PROGRESSIVE OSSEOUS HETEROPLASIA; PSEUDOHYPOPARATHYROIDISM TYPE 1A; ALPHA-SUBUNIT G(S)ALPHA; STIMULATORY G-PROTEIN; SKIN STEM-CELLS; OSTEOBLAST DIFFERENTIATION; INHIBITOR SCLEROSTIN; HORMONE RESISTANCE; HAIR FOLLICLE; G-ALPHA(S);
D O I
10.1007/s11914-022-00719-w
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Purpose of Review This review highlights the impact of Gnas inactivation on both bone remodeling and the development of heterotopic subcutaneous ossifications in Albright hereditary osteodystrophy (AHO). Here we discuss recent advancements in understanding the pathophysiologic mechanisms of the aberrant bone development in AHO as well as potential translational implications. Recent Findings Gnas inactivation can regulate the differentiation and function of not only osteoblasts but also osteoclasts and osteocytes. Investigations utilizing a mouse model of AHO generated by targeted disruption of Gnas have revealed that bone formation and resorption are differentially affected based upon the parental origin of the Gnas mutation. Data suggest that Gnas inactivation leads to heterotopic bone formation within subcutaneous tissue by changing the connective tissue microenvironment, thereby promoting osteogenic differentiation of tissue-resident mesenchymal progenitors. Observed variations in bone formation and resorption based upon the parental origin of the Gnas mutation warrant future investigations and may have implications in the management and treatment of AHO and related conditions. Additionally, studies of heterotopic bone formation due to Gnas inactivation have identified an essential role of sonic hedgehog signaling, which could have therapeutic implications not only for AHO and related conditions but also for heterotopic bone formation in a wide variety of settings in which aberrant bone formation is a cause of significant morbidity.
引用
收藏
页码:78 / 89
页数:12
相关论文
共 44 条
  • [1] Aberrant Bone Regulation in Albright Hereditary Osteodystrophy dueto Gnas Inactivation: Mechanisms and Translational Implications
    Patrick McMullan
    Emily L. Germain-Lee
    Current Osteoporosis Reports, 2022, 20 : 78 - 89
  • [2] Analysis of the GNAS1 gene in Albright's hereditary osteodystrophy
    Ahrens, W
    Hiort, O
    Staedt, P
    Kirschner, T
    Marschke, C
    Kruse, K
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2001, 86 (10): : 4630 - 4634
  • [3] Gnas heterozygous inactivation in a mouse model of Albright hereditary osteodystrophy differentially affects cortical bone formation based upon parental inheritance of mutation
    McMullan, Patrick
    Maye, Peter
    Rowe, David
    Germain-Lee, Emily
    JOURNAL OF BONE AND MINERAL RESEARCH, 2020, 35 : 300 - 300
  • [4] Case report: An infantile lethal form of Albright hereditary osteodystrophy due to a GNAS mutation
    Leclercq, Valerie
    Benoit, Valerie
    Lederer, Damien
    Delaunoy, Melanie
    Ruiz, Marcela
    de Halleux, Claire
    Robaux, Olivier
    Wanty, Catherine
    Maystadt, Isabelle
    CLINICAL CASE REPORTS, 2018, 6 (10): : 1933 - 1940
  • [5] Epigenetic defects of GNAS in patients with pseudohypoparathyroidism and mild features of Albright's hereditary osteodystrophy
    de Nanclares, Guiomar Perez
    Fernandez-Rebollo, Eduardo
    Santin, Izortze
    Garcia-Cuartero, Beatriz
    Gaztambide, Sonia
    Menendez, Edelmiro
    Morales, Maria Jose
    Pombo, Manuel
    Bilbao, Jose Ramon
    Barros, Francisco
    Zazo, Nuria
    Ahrens, Wiebke
    Jueppner, Harald
    Hiort, Olaf
    Castano, Luis
    Bastepe, Murat
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2007, 92 (06): : 2370 - 2373
  • [6] Albright hereditary osteodystrophy: report of a particular clinical phenotype caused by a novel GNAS mutation
    Alvarez, F.
    Kottler, M. L.
    Paul, C.
    Gennero, I.
    Salles, J. P.
    Mazereeuw-Hautier, J.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2010, 24 (08) : 974 - 975
  • [7] A Novel GNAS1 Mutation in a German Family with Albright's Hereditary Osteodystrophy
    Klagge, A.
    Jessnitzer, B.
    Pfaeffle, R.
    Stumvoll, M.
    Fuhrer, D.
    EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 2010, 118 (09) : 586 - 590
  • [8] Parental Origin of Gsα Inactivation Differentially Affects Bone Remodeling in a Mouse Model of Albright Hereditary Osteodystrophy
    McMullan, Patrick
    Maye, Peter
    Yang, Qingfen
    Rowe, David W.
    Germain-Lee, Emily L.
    JBMR PLUS, 2022, 6 (01)
  • [9] Molecular analysis of the GNAS1 gene for the correct diagnosis of Albright hereditary osteodystrophy and pseudohypoparathyroidism
    de Sanctis, L
    Romagnolo, D
    Olivero, M
    Buzi, F
    Maghnie, M
    Scirè, G
    Crinò, A
    Baroncelli, GI
    Salerno, M
    Di Maio, S
    Cappa, M
    Grosso, S
    Rigon, F
    Lala, R
    De Sanctis, C
    Dianzani, I
    PEDIATRIC RESEARCH, 2003, 53 (05) : 749 - 755
  • [10] A mouse model of Albright hereditary osteodystrophy generated by targeted disruption of Exon 1 of the Gnas gene
    Germain-Lee, EL
    Schwindinger, W
    Crane, JL
    Zewdu, R
    Zweifel, LS
    Wand, G
    Huso, DL
    Saji, M
    Ringel, MD
    Levine, MA
    ENDOCRINOLOGY, 2005, 146 (11) : 4697 - 4709